delete Therapeutic Goods Regulations (Amendment)
The Therapeutic Goods Regulations (Amendment) registered 17 July 2009 modifies requirements for therapeutic goods including registration, advertising, and compliance, extending the regulatory framework under the Therapeutic Goods Act 1989.
Therapeutic goods regulation inflates costs, delays life-saving treatments, and creates barriers to entry through government monopoly on approval. The compliance burden distorts market incentives, reduces supply, and harms patients through restricted access and higher prices. These costs outweigh any benefits, which could be achieved through private certification, tort liability, and industry self-regulation.